Last reviewed · How we verify
Donor Fecal Microbiota Transplantation
Donor Fecal Microbiota Transplantation is a Biologic drug developed by Madhusudan (Madhu) Grover, MBBS. It is currently in Phase 2 development.
At a glance
| Generic name | Donor Fecal Microbiota Transplantation |
|---|---|
| Sponsor | Madhusudan (Madhu) Grover, MBBS |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
- Diarrhoea
- Abdominal pain
- Defaecation urgency
- Nausea
- Abdominal distension
- Decreased appetite
- Abdominal tenderness
- Anal incontinence
- Dehydration
- Haematochezia
- Vomiting
- Urinary tract infection
Key clinical trials
- Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis (PHASE3)
- Effect of Oral Microbiota on MDRO Decolonization (PHASE1, PHASE2)
- Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Nationality in the Treatment of IBD (NA)
- Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure (PHASE1)
- Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC (PHASE2)
- Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder. (PHASE1, PHASE2)
- Transfer of Feces in Ulcerative Colitis 2 (PHASE2)
- Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Donor Fecal Microbiota Transplantation CI brief — competitive landscape report
- Donor Fecal Microbiota Transplantation updates RSS · CI watch RSS
- Madhusudan (Madhu) Grover, MBBS portfolio CI
Frequently asked questions about Donor Fecal Microbiota Transplantation
What is Donor Fecal Microbiota Transplantation?
Donor Fecal Microbiota Transplantation is a Biologic drug developed by Madhusudan (Madhu) Grover, MBBS.
Who makes Donor Fecal Microbiota Transplantation?
Donor Fecal Microbiota Transplantation is developed by Madhusudan (Madhu) Grover, MBBS (see full Madhusudan (Madhu) Grover, MBBS pipeline at /company/madhusudan-madhu-grover-mbbs).
What development phase is Donor Fecal Microbiota Transplantation in?
Donor Fecal Microbiota Transplantation is in Phase 2.
What are the side effects of Donor Fecal Microbiota Transplantation?
Common side effects of Donor Fecal Microbiota Transplantation include Diarrhoea, Abdominal pain, Defaecation urgency, Nausea, Abdominal distension, Decreased appetite.